ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 141 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $103,000 | +139.5% | 17,059 | +42.7% | 0.00% | – |
Q3 2019 | $43,000 | +43.3% | 11,955 | +6.3% | 0.00% | – |
Q2 2019 | $30,000 | +900.0% | 11,250 | +506.5% | 0.00% | – |
Q4 2018 | $3,000 | 0.0% | 1,855 | +98.4% | 0.00% | – |
Q3 2018 | $3,000 | 0.0% | 935 | -2.9% | 0.00% | – |
Q2 2018 | $3,000 | +200.0% | 963 | +124.0% | 0.00% | – |
Q4 2017 | $1,000 | -94.4% | 430 | -89.6% | 0.00% | – |
Q3 2017 | $18,000 | -93.1% | 4,118 | -92.7% | 0.00% | – |
Q2 2017 | $260,000 | +16.1% | 56,715 | +6.4% | 0.00% | – |
Q1 2017 | $224,000 | +11100.0% | 53,305 | +12296.5% | 0.00% | – |
Q4 2016 | $2,000 | -33.3% | 430 | 0.0% | 0.00% | – |
Q3 2016 | $3,000 | 0.0% | 430 | 0.0% | 0.00% | – |
Q2 2016 | $3,000 | -75.0% | 430 | -73.6% | 0.00% | – |
Q1 2016 | $12,000 | -89.5% | 1,630 | -84.6% | 0.00% | – |
Q4 2015 | $114,000 | +1325.0% | 10,585 | +782.1% | 0.00% | – |
Q3 2015 | $8,000 | -57.9% | 1,200 | -51.2% | 0.00% | – |
Q2 2014 | $19,000 | – | 2,460 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
Bellevue Group AG | 240,000 | $991,000 | 0.20% |